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Distinct and Essential Roles of Transcription
Factors IRF-3 and IRF-7 in Response
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region several regulatory cis-elements, consisting of
positive and negative elements (reviewed in Taniguchi,
1988; Maniatis et al., 1992). The positive elements con-
stitute a virus-inducible enhancer, which contains at
least four regulatory elements, designated as PRDI,
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The PRDI and -III elements are known to bind mem-Japan
bers of a family of transcription factors, termed inter-
feron regulatory factors (IRFs) (Fujita et al., 1988; Miya-
moto et al., 1988). Among the nine members of thisSummary
family (IRF-1, IRF-2, IRF-3, IRF4/Pip/ICSAT, IRF-5, IRF-6,
IRF-7, IRF-8/ICSBP [interferon consensus sequenceInduction of the interferon (IFN)-a/b gene transcription
binding protein], and IRF-9/ISGF3g [interferon-stimu-in virus-infected cells is an event central to innate
lated gene factor 3g]), four members, IRF-1, IRF-3, IRF-7,immunity. Mice lacking the transcription factor IRF-3
and IRF-9/ISGF3g, have been implicated in the tran-are more vulnerable to virus infection. In embryonic
scriptional induction of the IFN-a/b genes (reviewed infibroblasts, virus-induced IFN-a/b gene expression
Nguyen et al., 1997; Mamane et al., 1999; Taniguchi etlevels are reduced and the spectrum of the IFN-a
al., 2000). Previously, it has been shown that the ectopicmRNA subspecies altered. Furthermore, cells addi-
expression of IRF-1 results in the activation of IFN-a/btionally defective in IRF-7 expression totally fail to in-
promoters in transient assays (Harada et al., 1990) andduce these genes in response to infections by any of
that induction of the endogenous IFN-a/b genes alsothe virus types tested. In these cells, a normal profile
occurs in some cells (Fujita et al., 1989b). Subsequently,of IFN-a/b mRNA induction can be achieved by coex-
cells lacking IRF-1 have been generated by gene tar-pressing both IRF-3 and IRF-7. These results demon-
geting in mice, and it has been shown that the IFN-a/bstrate the essential and distinct roles of the two factors,
gene induction by Newcastle disease virus ([NDV]; para-which together ensure the transcriptional efficiency and
myxoviridae) still occurs normally, indicating that either
diversity of IFN-a/b genes for the antiviral response.
IRF-1 is not involved or that a redundant mechanism(s)
may be operating in the gene induction (Matsuyama et
Introduction al., 1993). Evidence has also been provided that an IFN-
activated transcription factor, ISGF3, which is a hetero-
Cells produce interferon (IFN)-a/b in response to infec- trimeric complex consisting of IRF-9 (ISGF3g or p48),
tion by a variety of viruses, an event known to be central signal transducer and activator of transcription (Stat)1
to the innate immune response of a host (reviewed in and Stat2, is involved in IFN-a/b gene induction (Kawa-
DeMaeyer and DeMaeyer-Guignard, 1988; Vilcek and kami et al., 1995; Harada et al., 1996; Yoneyama et al.,
Sen, 1996). In fact, virus infection results in the transcrip- 1996); however, it is still unclear whether ISGF3 directly
tional activation of IFN-a/b genes, and numerous stud- acts on the IFN-a/b genes (Harada et al., 1996; Yoneyama
ies have been carried out to elucidate the mechanisms et al., 1996). Recently, much attention has been focused
of the gene induction in response to virus infections, on two structurally related members, IRF-3 and IRF-7
particularly that of the IFN-b gene, which is present as a (reviewed in Mamane et al., 1999; Taniguchi et al., 2000).
single copy in humans and mice (reviewed in Weissmann IRF-3 and IRF-7 are both expressed in many cell types,
and Weber, 1986; Maniatis et al., 1992; Taniguchi et and they undergo phosphorylation and nuclear translo-
al., 2000). The IFN-b gene contains within its promoter cation in the event of virus infection of the cell. Further-
more, either of these factors, when expressed ectopi-
cally, can enhance the IFN-a/b mRNA induction levels§ To whom correspondence should be addressed (e-mail: tada@
m.u-tokyo.ac.jp). (Marie et al., 1998; Sato et al., 1998a, 1998b). In addition,
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Figure 1. Generation of Mice with IRF-3 Nulli-
zygosity
(A) Partial restriction map of the wild-type lo-
cus and targeting strategy for IRF-3 gene dis-
ruption. The region containing the putative
transcriptional initiation site (represented by
an asterisk) and the coding exon for the
N-terminal part of the DNA binding domain
(DBD, shown at the top) were replaced with a
pgk-neo cassette. The diphteria toxin A (DT-A)
cassette was attached at the 59 end of the
targeting vector as a negative selection marker.
The probe for genomic Southern blot analysis
is indicated by a thick bar. BH, BamHI; BX,
BstXI; S, SalI; S3, Sau3AI.
(B) Southern blot analysis of BamHI-digested
genomic DNA isolated from wild-type (1/1),
heterozygous mutant (1/2), and homozy-
gous mutant (2/2) mice.
(C) Whole-cell extracts from wild-type (1/1),
heterozygous (1/2), and homozygous (2/2)
MEFs were subjected to immunoblotting to
detect the IRF-3 protein.
(D) Flow cytometric analysis of lymphocyte
populations in IRF-32/2 mice. Single cell sus-
pensions were prepared from the thymus and
spleen from 8-week-old littermate mice and
stained with indicated combination of the fol-
lowing fluorochrome-conjugated monoclonal
antibodies: anti-CD4 FITC, anti-CD8 PE, anti-
CD3 FITC, anti-B220 PE, and anti-DX5 PE.
Viable cells (2 3 104) in the lymphocyte gate, as
defined according to side and forward scatters,
were analyzed. The numbers represent the
percentage of cells contained in each region.
(E) Survival rate of WT and IRF-32/2 mice after
EMCV infection. Ten WT and eleven IRF-32/2
mice were infected intraperitoneally with
EMCV (105 pfu), and the survival of these mice
was monitored daily. Four WT mice recovered
from infection and remained alive (monitored
up to 14 days).
(F) IFN levels in sera from EMCV-infected
mice. Six WT and IRF-32/2 mice were infected
with EMCV as in (E). Serum from each mouse
was prepared at day 3 postinfection and the
IFN level determined. The bars represent the
mean values of the IFN titer. All of the antiviral
activity was completely neutralized by adding
anti-IFN-a (clone 4E-A1, Yamasa Shoyu) and
anti-IFN-b (clone 7F-D3, Yamasa Shoyu)
monoclonal antibodies (data not shown).
IRF-3 is also known to bind to the coactivators CBP/ a4 and IFN-a5, are preferentially induced in mouse cells
(Weissmann and Weber, 1986; Marie et al., 1998). Itp300 (Lin et al., 1998; Sato et al., 1998a; Wathelet et
al., 1998; Yoneyama et al., 1998), and it has also been remains to be clarified how these IRFs actually partici-
pate in the regulation of this diversity of gene inductiondemonstrated that IRF-3 and IRF-7 form a complex,
termed virus-activated factor (VAF), that binds to the for the IFN-a gene family.
To assess the role of IRF-3 and IRF-7, we appliedIFN-b promoter (Wathelet et al., 1998). While IRF-3 is
constitutively expressed in normally growing cells, the the gene targeting strategy in the present study and
generated mice and mouse cells that do not expressIRF-7 expression is induced by IFN-a/b stimulation,
leading to the notion that IRF-3 is primarily responsible IRF-3 or both IRF-3 and IRF-7. We demonstrate that
both IRF-3 and IRF-7 perform nonredundant and distinctfor the induction of IFN-a/b genes in the early induction
phase and that IRF-7 is involved in the late induction roles from each other for the efficient IFN-a/b gene in-
duction, as well as for the diversity of the inductionphase (Marie et al., 1998; Sato et al., 1998b).
Despite the substantial interest in the roles of these mechanisms within the IFN-a gene family. Our present
study also indicates that the transcriptional induction ofIRF family members in IFN-a/b gene induction, it is still
unclear as to how these factors actually participate in IFN-a/b genes against infection by different types of
viruses is commonly dependent on these two IRF familythe gene induction by viruses. In this regard, it is also
worth noting that some IFN-a members, such as IFN- members.
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Figure 2. Expression of IFN-a/b and IRF-7
mRNAs in IRF-32/2 MEFs
(A) Induction of IFN-a/b mRNA in wild-type
(WT) and IRF-32/2 MEFs was analyzed by RNA
blotting; time after NDV infection is indicated.
Five micrograms of total RNA was loaded in
each lane. For IFN priming and cycloheximide
(CHX) treatment, MEFs were stimulated with
250 U/ml recombinant mouse IFN-b (TORAY)
for 6 hr and subsequently with 100 mg/ml CHX
1 hr prior to NDV infection. For blotting con-
trol, each membrane was reprobed using the
GAPDH probe ([A], [C], [D], and [E]).
(B) Induction profile of the IFN-a mRNA sub-
species. Total RNA from the indicated MEFs
infected with NDV was subjected to RT–PCR
using IFN-a consensus primers (Marie et al.,
1998). The obtained cDNA fragments were
subcloned, and 50 clones from each of the
MEFs were analyzed based on their se-
quences. In WT cells, none of the 50 clones
analyzed encoded IFN-a1 mRNA.
(C) Induction of IFN-a/b mRNA in IRF-32/2
MEFs and IRF-32/2/IRF-7 MEFs. The retrovi-
rus vector pBabe-hygro or His-IRF-7/pBabe-
hygro (IRF-7) was introduced into IRF-32/2
MEFs (IRF-32/2/IRF-7 MEFs). The cells were
treated with 100 mg/ml of CHX for 1 hr and
subsequently stimulated with recombinant
mouse IFN-b as in (A). After 1 hr, the cells
were infected with NDV. Total RNA was ex-
tracted at different times, as indicated, and
5 mg of total RNA from each time point was subjected to RNA blotting. The activation of ISGF3 was detected by EMSA using the ISRE (IFN-
stimulated response element) probe from the human 29-59 OAS gene (lower panel). Time (hr) after IFN treatment and NDV infection is indicated
at the upper part of the panel.
(D) Induction of IRF-7 mRNA in NDV-infected MEFs. WT, IRF-32/2, and IRF-9/ISGF3g2/2 MEFs were mock infected (2) or infected with NDV
for 12 hr (1) and total RNA extracted. Five micrograms from each sample was applied for RNA blotting.
(E) Expression of IRF-7 mRNA in normally growing MEFs. Three micrograms of poly(A) RNA prepared from WT, IRF-32/2, IRF-9/ISGF3g2/2, and
IFN-a/b receptor 1 (IFNAR1)2/2 MEFs was loaded onto each lane.
Results and Discussion hand, when IFN-mediated antiviral response of IRF-32/2
MEFs against VSV, EMCV, and herpes simplex virus
(HSV) was examined, the response was normal (dataIntroduction of IRF-3 Nullizygosity
The mouse IRF-3 gene, present as a single copy, was not shown).
cloned and a targeting vector constructed for the gener-
ation of IRF-3-deficient (IRF-32/2) mice (Figure 1A). The Impaired IFN-a/b Gene Induction in the Absence
of IRF-3expected nullizygosity was confirmed by Southern blot-
ting (Figure 1B) and immunoblot analysis of IRF-32/2 The IRF-32/2 MEFs were examined for the virus-induced
expression of IFN-a/b mRNAs. As shown in Figure 2A,mouse embryonic fibroblasts (IRF-32/2 MEFs) using an
anti-IRF-3 antibody (Figure 1C). Mutant IRF-3 heterozy- in a typical case, IFN-a/b mRNA expression levels, in-
duced by NDV, dramatically decreased (about 20- togous and homozygous mice showed no difference in
size, behavior, and reproductive ability as compared with 50-fold 12 hr after the viral infection) in IRF-32/2 MEFs,
as compared with those in WT MEFs. IFN-a/b levels inwild-type (WT) littermates. Since some IRF family mem-
bers play critical roles for the lymphocyte development the culture medium secreted from IRF-32/2 MEFs also
decreased (see Table 1). Furthermore, even the residualin mice (Matsuyama et al., 1993; Ogasawara et al., 1998),
we analyzed lymphocyte populations in the thymus and induction became undetectable when a protein synthe-
sis inhibitor, cycloheximide (CHX), was added to the cellspleen of IRF-32/2 mice, but no significant abnormality
was detected (Figure 1D). Interestingly, IRF-32/2 mice culture prior to the NDV infection. There have been many
reports demonstrating that the initial IFN-a/b gene in-were found to be more vulnerable to virus infection; all
of the 11 mice infected with the encephalomyocarditis duction in normally growing cells occurs in the presence
of CHX (Fujita et al., 1981; Harada et al., 1996), and ourvirus (EMCV) died within 6 days, whereas the similarly
infected WT mice were more resistant, and 4 out of 10 results indicate that IRF-3 is essential for this induction.
In addition, further analysis of the induced mRNA popula-mice recovered from infection (Figure 1E). Thus, IRF-3
is critical for the host defense against virus infection. tion revealed an abnormality in the spectrum of induction
for the IFN-a mRNA subspecies induced in the IRF-32/2Although the vulnerability of these IRF-32/2 mice may
involve many events, the IFN levels in serum from EMCV- MEFs: preferential induction of IFN-a1 and -a5 mRNAs,
along with IFN-a4 mRNA, which is the most predominantinfected mice were found to be significantly lower in
IRF-32/2 mice than in WT mice (Figure 1F). On the other species in WT MEFs, was observed (Figure 2B). Thus,
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Table 1. IFN Production in MEFs
Genotype IFN titer (unit/ml)
WT 2286
2685
IRF-32/2 138
154
IRF-9 (ISGF3g)2/2 608
548
DKO ,0.1
,0.1
IFN activities were determined by the procedure described in the
Experimental Procedures. MEFs (1 3 105) were seeded in to wells
of 12-well plates. After 12 hr of incubation, MEFs were infected
with 2.5 hemaggulutinin unit of NDV, and the culture medium was
collected after 24 hr of incubation. Virus in the medum was inacti-
vated by incubation at pH 2. All of the antiviral activity was neutral-
ized completely by adding anti-IFN-a (clone 4E-A1, Yamasa Shoyu)
and anti-IFN-b (clone 7F-D3, Yamasa Shoyu) monoclonal anti-
bodies.
the absence of IRF-3 expression results in the abnormal
expression profile of the IFN-a mRNA species, indicating
an additional, novel role of IRF-3 for acquiring normal
IFN-a mRNA induction profiles (see below).
Critical Role of IFN Signaling for Residual IFN-a/b
Gene Induction in IRF-3 Null Cells
Interestingly, when IRF-32/2 MEFs were pretreated with Figure 3. Stability of IRF-3 and IRF-7 Proteins
IFN-b (250 U/ml), a process known as “priming” (Stewart NIH/3T3 cell lines expressing HA-tagged IRF-3 or IRF-7 were pulse
labeled with [35S]methionine and [35S]cysteine. After the chase, cellet al., 1971), substantial levels of IFN-a/b mRNA induc-
extracts were prepared at the indicated times and subjected totion were observed even in the presence of CHX (Figure
immunoprecipitation using an anti-HA monoclonal antibody (clone2A). This result indicates that another factor(s) induced
12CA5, Boehringer Mannheim) by SDS-PAGE analysis. The incorpo-
by priming can function in the absence of IRF-3. It has rated radioactivity was measured by BAS5000 (Fujix). PEST se-
been shown that IFN-activated ISGF3 directly binds to quences of IRF-7 and their PEST-FIND scores were obtained using
the virus-inducible elements of IFN-a/b genes (Kawa- PEST-FIND (Rechsteiner and Rogers, 1996).
kami et al., 1995; Harada et al., 1996; Yoneyama et al.,
1996). More recently, it has been shown that IRF-7, an-
other member of the IRF family that is structurally related from IRF-9-deficient (IRF-92/2) mice (Figure 2D) (Kimura
et al., 1996; Sato et al., 1998b). Immunoblot analysisto IRF-3, is induced by IFN-a/b via ISGF3 activation
(Marie et al., 1998; Sato et al., 1998b). using an anti-IRF-7 antibody also revealed similar ex-
pression profiles of the IRF-7 protein (data not shown).The availability of IRF-32/2 MEFs provided us an op-
portunity to examine whether ISGF3 is involved directly, Furthermore, RNA blot analysis of poly(A) RNA revealed
that “constitutive” IRF-7 mRNA expression observed inor indirectly through IRF-7 induction, in the IFN-a/b gene
induction. IRF-32/2 MEFs, constitutively expressing IRF-7, the WT and IRF-32/2 MEFs is barely detectable in MEFs
lacking the IFN-a/b receptor 1 (IFNAR1) or IRF-9 (Figurewere prepared by retrovirus-mediated gene transfer, and
they were treated with IFN-b in the presence of CHX, 2E). Similar observations were also seen in splenocytes
from the respective mice (data not shown).followed by NDV infection. As shown in Figure 2C (upper
panel), mRNA for the 29-59 oligoadenylate synthetase These results may be interpreted in relation to the
induction mechanism of the IFN-a/b genes as follows.(29-59 OAS) gene, which is directly activated by ISGF3
(Kimura et al., 1996), was induced even in cells infected In the early phase, upon virus infection, the IFN-indepen-
dent pathway dominates in WT MEFs due to the consti-by a control retrovirus. On the other hand, the induction
of IFN-a/b mRNA was observed only in cells ectopically tutive expression of IRF-3 (Figure 1C), and signaling by
the newly synthesized IFNs further induces IRF-7 viaexpressing IRF-7. Under these conditions, both cells
showed sustained activation of ISGF3 1 hr after IFN-b strong activation of ISGF3 in the subsequent induction
phase (Marie et al., 1998; Sato et al., 1998b). In IRF-32/2stimulation, as revealed by the electrophoresis mobility
shift assay (EMSA) (Figure 2C, lower panel). These data MEFs, the IFN-dependent pathway, leading to IRF-7 ex-
pression, is still operational but inefficient, since thefurther lend support to the notion that ISGF3-induced
IRF-7, rather than ISGF3 per se, acts on IFN-a/b genes early IFN-a/b induction is solely dependent on low levels
of IRF-7 expression. In fact, this low level of IRF-7 ex-(Marie et al., 1998; Sato et al., 1998b). As shown in Figure
2D, IRF-7 mRNA is strongly induced following NDV infec- pression in uninfected cells is sustained through signal-
ing by IFN-a/b, which are spontaneously expressed attion of WT MEFs. Interestingly, IRF-7 mRNA induction
by NDV still occurs in IRF-32/2 MEFs, albeit inefficiently; very low levels (Takaoka et al., 2000). Consistently, we
found that in IRF-32/2 splenocytes, constitutive IRF-7however, this induction is completely abolished in MEFs
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mRNA expression levels were much higher than that of
MEFs and that the IFN-a/b mRNA induction was also
higher in these splenocytes than in MEFs (data not
shown; see below). It is also known that expression of
IRF-7 per se (for example, by IFN priming) is insufficient
to induce IFN-a/b genes, and it requires about 6 hr
after virus infection to undergo modification and nuclear
translocation (Au et al., 1998); this would explain the
result (shown in Figure 2A) that in IFN-primed cells, it
still takes 6 hr before the gene induction.
It is worth noting that the IFN-a/b mRNA expression
level is undetectable and low in the “unprimed” and
“primed” IRF-32/2 MEFs, respectively, in the presence
of CHX (Figure 2A). This observation suggests the impor-
tance of ongoing de novo protein synthesis for the effi-
cient functioning of IRF-7. In this regard, we found a
notable difference in terms of the stability of IRF-3 and
IRF-7; IRF-7 has a very short half-life (0.51 z1 hr),
Figure 4. Induction of IFN-a and IFN-b mRNAs in IRF-3/(IRF-9/
whereas IRF-3 is very stable (Figure 3). Using the algo- ISGF3g) DKO Cells
rithm PEST-FIND (Rechsteiner and Rogers, 1996), IRF-7
(A) Induction of IFN-a/b mRNA by NDV infection in MEFs was ana-
was found to have a potential proteolytic signal called lyzed by RNA blotting; time after NDV infection is indicated. NDV
the PEST sequence, which is rich in proline (P), glutamic replication was confirmed by identification of the NDV-nucleocapsid
protein (NDV-NP) mRNA expression. Five micrograms of total RNAacid (E), serine (S), and threonine (T) (Rogers et al., 1986).
was loaded onto each lane. For the blotting control, each membraneA potential PEST sequence was found in IRF-7 but not
was reprobed with the GAPDH probe (A–C).in IRF-3 (Figure 3). Although further work is necessary, it
(B) Induction of IFN-a and IFN-b mRNAs in splenocytes. Splenocytesis possible that this sequence accounts for the selective
from wild-type (WT) and IRF-3/(IRF-9/ISFG3g) DKO mice were in-
instability of IRF-7, which would explain the low induc- fected with NDV for 8 hr. Total RNA (0.8 mg) was subjected to RNA
tion level of IFN-a/b mRNA in the presence of CHX in blot analysis.
(C) Induction of IFN-a and IFN-b mRNAs by VSV, HSV, and EMCVIRF-32/2 MEFs.
infections. One microgram of poly(A) RNA was subjected to RNA
blotting (lanes at 12 hr and 18 hr after EMCV infection, 0.1 mg ofComplete Loss of IFN-a/b Gene Induction in the
poly(A) RNA was loaded). RNA yield from EMCV-infected MEFs was
Absence of Both IRF-3 and IRF-7 Expression quite low because of the inhibition of transcription by EMCV (Cas-
To further examine the contribution of IRF-3 and IRF-7 trillo and Carrasco, 1986). All of the cells underwent virus-induced
cell death (Tanaka et al., 1998) 24 hr after infection.in the IFN-dependent and -independent IFN-a/b gene
induction mechanisms, we next generated mice doubly
deficient for IRF-3 and IRF-9 (DKO mice) by crossing
(herpesviridae). Interestingly, the induction of IFN-a/bIRF-32/2 mice with IRF-92/2 mice (Kimura et al., 1996).
mRNA expression by these viruses, which can be dem-As shown in Figure 4A, the IRF-7 mRNA induction is
onstrated in WT MEFs, is again not observed in thetotally abolished in DKO cells, whereas IRF-1 mRNA,
mutant cells (Figure 4C), indicating the general impor-encoding another transcription factor also implicated in
tance of IRF-3 and IRF-7 in regulating the two-phasedthis process, is still inducible (data not shown). Interest-
IFN-a/b gene induction mechanism.ingly, the IFN-a/b mRNA induction was completely abol-
ished in the DKO MEFs and splenocytes (Figures 5A
and 5B), and, as expected, the IFN-a/b activity was Restoration of IFN-a/b Gene Inducibility in DKO Cells
by Ectopic Expressions of IRF-3 and/or IRF-7undetectable in the culture supernatant (Table 1). Thus,
DKO MEFs are incapable of responding to NDV infection The generation of DKO MEFs also provided an opportu-
nity to examine the function of IRF-3 and IRF-7 in thein terms of IFN-a/b mRNA induction. Consistent with
this finding, the nuclear run-on assay revealed the ab- absence of either factor in the induction of IFN-a/b
genes. In these DKO MEFs, the IFN-b gene inductionsence of any transcriptional induction of IFN-b gene
in DKO MEFs (M. S., unpublished data). These results by NDV is restored by the retrovirus-mediated expres-
sion of IRF-3 (Figure 5A). It is noteworthy that the IRF-3further underscore the essential role of IRF-3 for the
IFN-independent IFN-a/b gene induction and suggest expression is associated with efficient IFN-b mRNA in-
duction, whereas only a marginal induction was achievedthe involvement of IRF-7 in IFN-dependent gene induc-
tion. The results also suggest that IRF-3 is not effective for IFN-a mRNA, an observation consistent with the data
shown in Figure 5A. On the other hand, IRF-7 expressionin the induction of IFN-a genes in the absence of IRF-7
expression (see below). resulted in the induction of both IFN-a and IFN-b genes
(Figure 5A), indicating that IRF-7 can function in theIt has been well documented that infection by a variety
of viruses commonly results in IFN-a/b gene induction absence of IRF-3 (see below). It is worth noting that a
similar expression of IRF-1 had little, if any, effect on(reviewed in DeMaeyer and DeMaeyer-Guignard, 1988;
Vilcek and Sen, 1996). Therefore, IFN-a/b mRNA induc- the gene induction in our assay system (data not shown),
indicating further that IRF-1 contributes little, if any, totion was examined in DKO MEFs infected with three
other different types of viruses, i.e., EMCV (picornaviri- the virus-induced expression of IFN-a/b genes.
Although IRF-7 expression alone can prima facie con-dae), vesicular stomatitis virus (rhabdoviridae), and HSV
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fer IFN-a gene inducibility on DKO MEFs, an abnormality
similar to that observed in IRF-32/2 MEFs (Figure 2B)
was found in the induction spectrum for the IFN-a mRNA
subspecies (Figure 5B). In fact, the preferential induction
of IFN-a1 and -a5 mRNAs was again observed in cells
expressing solely IRF-7 (Figure 5B). However, this skew-
ing of the mRNA induction profile could be corrected
by the concomitant expression of IRF-3, resulting in an
mRNA induction spectrum similar to that of the WT cells.
In fact, the induction of IFN-a4 mRNA is dominant in
cells expressing both IRF-3 and IRF-7, as in the WT cells
(Figures 2B and 5B). Taken together with the observation
that IRF-3 is ineffective per se to cause a high-level IFN-
a4 mRNA induction, it is likely that IRF-3 and IRF-7 must
cooperate for the induction of the IFN-a4 gene. It is also
possible that such a cooperation occurs in IFN-b gene
induction, when both factors are present at high levels
(Figure 5A). Thus, a deficiency in the IRF-9 gene in DKO
MEFs can be fully rescued by the ectopic expression
of IRF-7; IRF-7 may be the main or only target gene of
the IFN-a/b-activated ISGF3, involving IRF-9/ISGF3g, in
terms of the transcriptional induction of IFN-a/b genes.
By transient expression of the cDNAs for IRF-3 or
IRF-7, we found that both homo- and heteromeric com-
plex formations occur even in the absence of viral infec-
tion and that these homo- and heteromeric complexes
undergo phosphorylation upon viral infection (N. H., un-
published data). Although further studies are required
for elucidating the detailed mechanism, these results
indicate that IRF-3 and IRF-7 homomeric complexes
have functions distinct from each other, in that the for-
mer is active in inducing the IFN-b gene but rather inert
in the case of the IFN-a gene, while the latter preferen-
tially acts on the IFN-a1 and -a5 genes. On the other
hand, the IRF-3/IRF-7 heteromeric complex, the forma-
tion of which has been reported previously (Wathelet et
al., 1998), is more critical for the IFN-dependent, late
phase IFN-a/b gene induction to induce the IFN-b and
IFN-a4 genes more efficiently.
Figure 5. Effects of Retrovirus-Mediated Expression of IRF-3 and Activation of IFN-b Promoter in DKO Cells
IRF-7 in IRF-3/(IRF-9/ISGF3g) DKO MEFs In view of previous reports indicating that both IRF-3
(A) The expression of IFN-a and IFN-b mRNAs in DKO MEFs express- and IRF-7 act on the virus-inducible IFN-b promoter (Au
ing IRF-3 and/or IRF-7. The following retrovirus vectors were intro- et al., 1998; Juang et al., 1998; Lin et al., 1998; Marie et
duced into DKO or wild-type (WT) MEFs: pBabe-puro and pBabe-
al., 1998; Sato et al., 1998a; Schafer et al., 1998; Wathelethygro (control 1 control), HA-IRF-3/pBabe and pBabe-hygro (IRF-3 1
et al., 1998; Yoneyama et al., 1998), the IFN-b promotercontrol), pBabe-puro and His-IRF-7/pBabe-hygro (control 1 IRF-7),
activation was examined in these cells by transient ex-and HA-IRF-3/pBabe and His-IRF-7/pBabe-hygro (IRF-3 1 IRF-7).
These MEFs were mock infected (2) or infected with NDV for 12 hr pression of the promoter-driven luciferase reporter
(1) and total RNA prepared. Five micrograms of total RNA was gene. As shown in Figure 5C, promoter activation no
loaded onto each lane. Western blot analysis revealed that the level longer occurs in DKO MEFs, whereas it does occur in the
of ectopically expressed IRF-7 protein was approximately the same
cells in which IRF-3 or IRF-7 is ectopically expressed.as that of the NDV-infected MEFs and that the IRF-3 level was also
similar to that of WT MEFs (data not shown). Although IRF-1 has
also been implicated in IFN-a /b gene induction (Miyamoto et al.,
1988; Harada et al., 1990), it had no effect on IFN-a/b gene expres-
sion (N. H., unpublished observation). As control, the same mem- The dominant IFN-a subspecies found in cells expressing only IRF-3
(IRF-3 1 control) was IFN-a4 (M.A., unpublished observation).brane was reprobed with the GAPDH probe.
(B) Induction profile of the IFN-a mRNA subspecies. Total RNA from (C) IFN-b promoter activation by IRF-3 and IRF-7. The reporter plas-
mids, which contain the wild-type (pMu-125 luc) or mutant (pmtMu-the indicated MEFs infected with NDV was subjected to RT–PCR.
The obtained cDNA fragments were subcloned, and 50 clones from 125 luc) promoter sequence from the IFN-b gene, were transfected
into the MEFs used in (A). The levels of luciferase activity in indicatedeach of the MEFs were analyzed based on their sequences. Only
one clone encoding IFN-a1 mRNA was detected in cells expressing MEFs with (1) or without (2) NDV infection were measured. The
mean values of five independent samples and standard deviationboth IRF-3 and IRF-7. (Note that in cells expressing only IRF-7,
clones corresponding to IFN-a1, as well as IFN-a5, are dominant.) are presented.
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pendent, IRF-3 functions mainly for the IFN-b gene in-
duction. On the other hand, in the late phase IRF-3 is
also critical for two reasons: for the potentiation of the
overall IFN-a/b mRNA induction and for full procurement
of the normal mRNA induction profile for IFN-a subspe-
cies by cooperating with IRF-7. Clearly, IRF-7 is more
critical for the late induction phase. However, if the cells
are exposed to IFNs prior to virus infection, IRF-7 levels
will become upregulated, and it will also participate in
the early induction phase. In fact, in the “primed” IRF-32/2
MEFs, the mRNA expression levels are not significantly
different from those in WT MEFs, and IFN-a/b gene
induction is more efficient if CHX is not present (M. S.,
unpublished data). It is interesting to note that the IFN-
induced IRF-7 has a very short half-life (Figure 3). The
significance of this finding is not totally clear at present,
but one may speculate that this labile nature of IRF-7
may represent a mechanism critical in making the entire
IFN gene induction process transient (see Figure 2A).
Obviously, it is important and interesting to examine the
phenotype of the mice deficient in the IRF-7 gene, and
work is in progress to generate the mutant mice.
One question that remains to be resolved is the de-
tailed mechanism by which IFN genes are constitutively
expressed. In fact, reverse transcriptase–PCR (RT–PCR)
analysis revealed the expression of both IFN-a and
IFN-b mRNAs even in DKO MEFs (M. A., unpublished
observation). It is possible that the negative regulation
of IFN-a/b genes, as proposed previously (Goodbourn
et al., 1986; Civas et al., 1991; Nourbakhsh et al., 1993),
may not cause complete gene repression, thereby allow-
ing low-level, constitutive IFN production. Whatever theFigure 6. Schematic Representation of the Biphasic Mechanism for
mechanism underlying the constitutive IFN production,IFN-a/b Gene Induction, Mediated by IRF-3 and ISGF-3-Induced
IRF-7 the spontaneously produced IFNs may be biologically
In the early phase, constitutively expressed IRF-3 is activated by significant, since their level would have profound effect
virus infection, and this activation results in efficient and weak acti- on the positive feedback loop of IFN production by alter-
vations of IFN-b and IFN-a4 genes, respectively. In this phase, IRF-7 ing the IRF-7 levels in the cell; that is, spontaneously
is expressed only at very low levels in MEFs by spontaneous IFN-
produced IFNs would ensure a rapid and effective re-a/b signaling. This induction of IFN-a/b production results in a strong
sponse of the host to effectively induce IFN-a/b genesinduction of IRF-7 expression through activation of ISGF3 by IFN-
a/b signaling. Thus, in the late phase, IRF-3 and IRF-7 cooperate upon virus infection. In fact, this mechanism may have
with each other for amplification of IFN-a/b gene induction, resulting evolved to allow rapid antiviral responses to a variety
in the full procurement of the normal mRNA induction profile of the of viruses to afford a more efficient protection of a host.
IFN-a gene subfamily. It is worth noting that if cells are exposed to
higher levels of IFNs prior to virus infection (dashed line), this positive
feedback loop starts functioning more promptly and efficiently, even Experimental Procedures
in the absence of IRF-3. Note that this figure is similar but distinct
from results of previous reports (Marie et al., 1998; Sato et al., 1998b) Generation of Mice with IRF-3 Nullizygosity
in that it incorporates the data in the present work. To construct a targeting vector, a 13 kb genomic fragment was
isolated from the C57BL/6N mouse genomic library (Clontech). The
vector was designed to disrupt a 2.2 kb BstXI/BamHI region thatFurthermore, mutations introduced in one of the critical
contains a putative transcription initiation site and amino acids 1 to
IRF binding sequences (i.e., PRDI) (Fujita et al., 1988) 35 of the mouse IRF-3 gene (see Figure 1A). Fifty micrograms of
resulted in a significant decrease in the promoter activity linearized targeting vector was electroporated into CCE ES cells
(Figure 5C). These results suggest that the absence of as described previously (Robertson, 1991). Clones that survived
selection in 200 mg/ml G418 (GIBCO-BRL) were screened by PCRendogenous IFN-b gene induction in mutant MEFs is,
using the following oligonucleotide primers: IRF-3 sense, 59-TGACTat least in part, due to the lack of IFN-b promoter activa-
TCTCATCCTAACCCATGGG-39 and Neor antisense, 59-CCTGCTTtion by IRF-3 and/or IRF-7.
GCCGAATATCATGGTG-39. Three positive clones were obtained and
the homologous recombination confirmed by Southern blot analysis
Biphasic Induction of IFN-a/b Genes by IRF-3 using the 300 bp Sau3AI/HindIII fragment (see Figure 1A) as the
and IRF-7 probe. The positive clones were injected into C57BL/6J blastocysts.
Our present study indicates the essential role of IRF-3 Chimeric male founder mice were crossed with C57BL/6J females
in both early and late phases of IFN-a/b gene induction to obtain heterozygous F1 offspring. The IRF-3-deficient mice were
generated by interbreeding heterozygous mice.(Figure 6). In the early phase, which is mostly IFN inde-
Immunity
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Flow Cytometric Analysis His-tagged IRF-3 and IRF-7 retrovirus expression vectors His-IRF-
3/pBabe-hygro and His-IRF-7/pBabe-hygro were constructed asCells were incubated on ice with monoclonal antibodies for 30 min
and analyzed by flow cytometry (FACScalibur; Becton Dickinson) follows. To obtain the pBabe-hygro vector, the neomycin resistance
gene of pBabe-puro was substituted with a 1.2 kb HindIII/BglII hy-using CELLQuest software (Becton Dickinson). The monoclonal anti-
bodies used in this study were as follows: anti-mouse CD3e (fluores- gromycin resistance gene cassette from the pgk-hyg vector. After
the ligation of IRF-3 or IRF-7 cDNA fragments into the BamHI sitecein isothiocyanate [FITC] conjugated, clone 145-2C11), anti-mouse
CD8 (phycoerythrin [PE] conjugated, clone 53-6.7), anti-mouse CD4 of pET15b (Novagen), His-tagged IRF-3 and IRF-7 cDNA fragments
were prepared by EcoRV/XbaI digestion. Each fragment was cloned(FITC conjugated, clone GK1.5), anti-mouse B220 (PE conjugated,
clone RA3-6B2), and anti-mouse DX5 (PE conjugated). All mono- into the BamHI site of a pBabe-hygro. Retrovirus packaging and
infection were performed as described previously (Sato et al.,clonal antibodies were purchased from Pharmingen.
1998b). To express two different retrovirus vectors, the MEFs were
infected with HA-IRF-3/pBabe or pBabe-puro and selected in DMEMAntibodies and Immunoblot Analysis
containing 3 mg/ml puromycin (Sigma) for 3 days. The MEFs wereAnti-IRF-3 antiserum was obtained from New Zealand white rabbits
then subjected to a second infection with His-IRF-3/pBabe-hygro,immunized with a synthetic oligopeptide corresponding to amino
His-IRF-7/pBabe-hygro, or pBabe-hygro and cultured for 3 days inacids 147 to 161 of the mouse IRF-3. The antiserum was further purified
DMEM containing 100 mg/ml of hygromycin (Sigma).by peptide affinity column chromatography. Immunoblot analysis
was performed as described previously (Takaoka et al., 1999).
Transient Transfection Analysis
To construct the reporter plasmid pMu-125 luc, the murine IFN-bCells and RNA Blot Analysis
promoter region (2125 to 155) was amplified by PCR using senseMEFs were isolated and cultured as described previously (Harada
59-AGCTTGAATAAAATGCTAGCTAGAAGCTGTTAGAA-39 and anti-et al., 1996). All of the experiments were carried out and repeated
sense 59-CAAGATGAGGCAAAGCTTCAAAGGCTGCAGTGAGAAT-39with several lines of MEFs. The MEFs used in this study were not
primers, and the resulting fragment was ligated into the NheI/HindIIIpassaged for more than five times. NDV infection of MEFs or spleno-
gap in the Picagene luciferase reporter plasmid (Wako). The othercytes was performed at a concentration of 25 hemagglutinin units
reporter plasmid, in which two point mutations were introduced intoper 1 3 106 cells. HSV, VSV, and EMCV were allowed to adsorb
IRF-E, was constructed as follows. Two synthetic oligonucleotides,onto the MEFs for 1 hr at a concentration of 0.1, 0.1, and 1.0 plaque-
sense 59-GAATAAAATGAATATTAGAAGCTGTTAGAATAAGAGAAAAforming unit per cell, respectively. Total RNA isolation and RNA
TGACAGAGGAAAACTGAAAGGGAGAACGGAAAGGGGGAAATTCCblotting analysis were performed as described previously (Harada
TCTGAGGCAG-39 and antisense 59-TGAGGCAAAGGCTGTCAAAGet al., 1990, 1996; Sato et al., 1998b). Poly(A) RNA was prepared
GCTGCAGTGAGAATGATCTTCCTTCATGGCCTGGTGCTATTTATAusing Micro-FastTrack (Invitrogen). To prepare the probe, the follow-
AGGGATGGTCCTTTCTGCCTCAGAGGAATTTCCCCCC-39, were an-ing DNAs were labeled by the multiprime labeling reaction (TaKaRa).
nealed, and the recessed 39 termini were filled with Pyrobest DNAIFN-a is a 690 bp HindIII–EcoRI fragment from the mouse IFN-a
polymerase (TaKaRa). The resultant fragment was ligated into thegenomic clone pBR327(HindIII)/chrMuIFN-a1/pGS3 (Shaw et al.,
Picagene vector as described above. DNA transfection and lucifer-1983). This IFN-a probe detects multiple IFN-a subspecies. IFN-b
ase assays were performed as described previously (Sato et al.,is a 500 bp BamHI–BglII fragment from mouse IFN-b genomic clone
1998a). Briefly, MEFs were seeded into wells of 24-well plates andpMGb3-1 (T. Kuga and T. T., unpublished data). 29-59 OAS is a 1.4
transfected with 0.2 mg of the reporter plasmid (pMu-125 luc orkb EcoRI fragment from pMA25 (Ichii et al., 1986). The 850 bp NDV-
pmtMu-125 luc). After 36 hr, NDV was allowed to adsorb onto theNP (GenBank AF060483) and 1.0 kb GAPDH cDNA probes were
cells for 12 hr and then the levels of luciferase activity measured.prepared by RT–PCR using NDV-NP primers (sense, 59-ATGTCTTC
CGTATTCGACGAGTACG-39; antisense, 59-GGCTACTAAGTGCAAG
Quantification of IFN ActivityGGCTGATG-39) and GAPDH primers (sense, 59-ATGGTGAAGGTCG
Virus in the culture medium was inactivated by incubation at pH 2GTGTGAAC-39; antisense, 59-TTACTCCTTGGAGGCCATGTAG-39).
for 4 days at 48C. L929 cells were incubated in serially diluted culture
medium for 24 hr and subsequently challenged with VSV (MOI 5Electorophoresis Mobility Shift Assay
0.01) for 36 hr. The cells were then fixed with 10% formaldehydeCell extracts were prepared as described previously (Harada et al.,
and stained with crystal violet. The cytopathic effect was scored1990). 32P-labeled ISRE oligo DNA probe (10 fmol), 3 mg of herring
and the IFN titer was calculated. A reference mouse IFN-b (TORAY)sperm DNA, and 2 mg of poly(dG-dC):poly(dG-dC) were incubated
was used as a standard for measuring IFN activity.with 15 mg of cell extract at 258C for 30 min in a final volume of 15
ml of a buffer containing 20 mM HEPES (pH 7.5), 0.1 mM EDTA, 0.5
AcknowledgmentsmM DTT, 1 mM MgCl2, 50 mM NaCl, and 5% glycerol. The samples
were resolved on 4.8% polyacrylamide gels at 48C. The sequences
We thank Drs. E. Barsoumian, S. Taki, S. Hida, and T. Yokochi forof ISRE oligonucleotides used in the assay were 59-AGCTTCTGAG
invaluable advice and Dr. H. Takeshima for providing pgk-hyg vec-GAAACGAAACCAACAG-39 and 59-GATCCTGTTGGTTTCGTTTCCT
tor. This work was supported in part by a special grant for AdvancedCAGA-39.
Research on Cancer from the Ministry of Education, Science, Sports,
and Culture of Japan.
Detection of Stabilities of IRF-3 and IRF-7 Proteins
HA-tagged mouse IRF-3 (HA-IRF-3) or IRF-7 (HA-IRF-7) cDNA was
Received May 10, 2000; revised August 14, 2000.
introduced into NIH 3T3 cells using retrovirus expression vectors
and stable cell lines were obtained (Sato et al., 1998a, 1998b). These
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